These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6661346)

  • 1. Cardiovascular effects of AQ-A 39 in healthy volunteers.
    Hilaire J; Broustet JP; Colle JP; Theron M
    Br J Clin Pharmacol; 1983 Dec; 16(6):627-31. PubMed ID: 6661346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of AQ-A 39 with propanolol and placebo in ischaemic heart disease.
    Gilfrich HJ; Oberhoffer M; Witzke J
    Eur Heart J; 1987 Dec; 8 Suppl L():147-51. PubMed ID: 3330526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of falipamil (AQ-A 39) on heart rate and blood pressure in resting and exercising healthy volunteers.
    Naudascher M; Jaillon P; Lecocq B; Lecocq V; Ferry A; Hilaire J; Maria JF
    J Cardiovasc Pharmacol; 1989 Jul; 14(1):1-5. PubMed ID: 2475699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AQ-A 39 (5,6-dimethoxy-2-[3[[alpha-(3,4-dimethoxy)-phenylethyl]methylamino]propyl]phtalimidine), a specific bradycardic agent with direct action on the heart.
    Kobinger W; Lillie C
    Eur J Pharmacol; 1981 Jun; 72(2-3):153-64. PubMed ID: 7250205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AQ-AH 208, a new bradycardic agent, increases coronary collateral blood flow to ischemic myocardium.
    Daemmgen JW; Gross GJ
    J Cardiovasc Pharmacol; 1985; 7(6):1048-54. PubMed ID: 2418287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of cardiovascular responses to the bradycardic drugs, alinidine, AQ-A 39, and mixidine, in the anesthetized dog.
    Siegl PK; Wenger HC; Sweet CS
    J Cardiovasc Pharmacol; 1984; 6(4):565-74. PubMed ID: 6206308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular responses to increasing plasma concentrations of AQ-A 39 Cl, a new compound with negative chronotropic effects.
    Verdouw PD; Bom HP; Bijleveld RE
    Arzneimittelforschung; 1983; 33(5):702-6. PubMed ID: 6683548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analyses of the cardiac action of the bradycardic agent, AQ-A 39, by use of isolated, blood-perfused dog-heart preparations.
    Kawada M; Satoh K; Taira N
    J Pharmacol Exp Ther; 1984 Feb; 228(2):484-90. PubMed ID: 6694121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autonomic blockade and cardiovascular responses to static exercise in partially curarized man.
    Mitchell JH; Reeves DR; Rogers HB; Secher NH; Victor RG
    J Physiol; 1989 Jun; 413():433-45. PubMed ID: 2600859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The action of a new calcium antagonist 5,6-dimethoxy-2-(3 [(alpha-(3,4-dimethoxy)-phenylethyl)methylamino] propyl)-phthalimidine hydrochloride (AQ-A 39cl) on hemodynamics and ischemia parameters in exercise ECG of patients with coronary heart disease].
    Jost S; Schulz W; Kober G
    Arzneimittelforschung; 1985; 35(8):1279-82. PubMed ID: 4074444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular actions of 5,6-dimethoxy-2-(3-[(alpha-(3,4-dimethoxy) phenylethyl)-methylamino] propyl) phthalimidine (AQ-A 39), a specific bradycardic agent.
    Dämmgen J; Kadatz R; Diederen W
    Arzneimittelforschung; 1981; 31(4):666-70. PubMed ID: 7195712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of AQ-A39, a bradycardic agent, on cardiovascular responses to isoproterenol in the anesthetized dog.
    Wenger HC; Siegl PK
    J Cardiovasc Pharmacol; 1987 Feb; 9(2):246-53. PubMed ID: 2436007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiological studies on effects of AQ-A 39 in the isolated guinea pig heart and myocardial preparations.
    Hohnloser S; Weirich J; Homburger H; Antoni H
    Arzneimittelforschung; 1982; 32(7):730-4. PubMed ID: 6889873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of nifedipine and AQ-A 39 on the sinoatrial and atrioventricular nodes of the rabbit and their antiarrhythmic action on atrioventricular nodal reentrant tachycardia.
    Senges J; Rizos I; Brachmann J; Anders G; Jauernig R; Hamman HD; Kübler W
    Cardiovasc Res; 1983 Mar; 17(3):132-44. PubMed ID: 6871903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effects of two specific bradycardic agents AQ-A39 (falipamil) and AQ-AH 208 on reversible myocardial reperfusion damage in anesthetized dogs.
    Gross GJ; Daemmgen JW
    J Pharmacol Exp Ther; 1986 Aug; 238(2):422-8. PubMed ID: 3735124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of captopril, propranolol, and verapamil on arterial pulse wave velocity and other cardiovascular parameters in healthy volunteers.
    Kähönen M; Ylitalo R; Kööbi T; Turjanmaa V; Ylitalo P
    Int J Clin Pharmacol Ther; 1998 Sep; 36(9):483-9. PubMed ID: 9760009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of verapamil on cardiovascular and metabolic responses to exercise.
    Petri H; Arends BG; van Baak MA
    Eur J Appl Physiol Occup Physiol; 1986; 55(5):499-502. PubMed ID: 3095111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The relation between myocardial oxygen consumption and ischemia during exertion in patients with angina pectoris: effect of propranolol].
    Galvani M; Bugiardini R; Ferrini D; Gridelli C; Mari L; Pozzati A; Ferramosca B; Puddu P
    G Ital Cardiol; 1985 Nov; 15(11):1032-8. PubMed ID: 3007250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic effects of acebutolol and propranolol in hypertensive patients during exercise.
    Reim HG; Wagner W
    Int J Clin Pharmacol Ther Toxicol; 1985 May; 23(5):238-43. PubMed ID: 4008112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of ivabradine, a selective heart rate-lowering agent, and propranolol on systemic and cardiac haemodynamics at rest and during exercise.
    Joannides R; Moore N; Iacob M; Compagnon P; Lerebours G; Menard JF; Thuillez C
    Br J Clin Pharmacol; 2006 Feb; 61(2):127-37. PubMed ID: 16433867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.